SCHEMBL9818879

SCHEMBL9818879

CC1CC(=O)c2cc(Cl)c(Cl)cc2O1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PBRM1 Q86U86 1/20 0.58
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
ALDH1A1 P00352 2/20 0.40
MAPT P10636 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MEN1 O00255 1/20 0.40
NPC1 O15118 1/20 0.40
ALPL P05186 1/20 0.40
POLB P06746 1/20 0.40
ALPI P09923 1/20 0.40
GAA P10253 1/20 0.40
ALPG P10696 1/20 0.40
THRB P10828 1/20 0.40
APEX1 P27695 1/20 0.40
MAPK1 P28482 1/20 0.40
RECQL P46063 1/20 0.40
GCGR P47871 1/20 0.40
RAB9A P51151 1/20 0.40
VCP P55072 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9819094 1.00 PBRM1 (0.58) PBRM1CNR1CNR2ALDH1A1MAPT
SCHEMBL10713025 0.96 PBRM1 (0.55) PBRM1CNR1CNR2ALDH1A1MAPT
Lithium Ion SCHEMBL10713022 0.95 PBRM1 (0.54) PBRM1CNR1CNR2ALDH1A1MAPT
SCHEMBL9818866 0.89 PBRM1 (0.51) PBRM1CNR1CNR2ALDH1A1MAPT
SCHEMBL9818870 0.89 PBRM1 (0.51) PBRM1CNR1CNR2ALDH1A1MAPT
SCHEMBL9819284 0.86 PBRM1 (0.60) PBRM1CNR1CNR2ALDH1A1MAPT
SCHEMBL9819184 0.86 PBRM1 (0.53) PBRM1CNR1CNR2ALDH1A1MAPT
SCHEMBL9818930 0.86 PBRM1 (0.53) PBRM1CNR1CNR2ALDH1A1MAPT
SCHEMBL9818735 0.85 PBRM1 (0.51) PBRM1CNR1CNR2ALDH1A1MAPT
SCHEMBL9819009 0.84 PBRM1 (0.50) PBRM1ALDH1A1KDM4EMEN1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0230379-B1 CHROMAN- AND THIOCHROMAN-4-ACETIC ACIDS USEFUL IN THE TREATMENT OF DIABETIC COMPLICATIONS PFIZER INC. (US) 1991-04-03 EP disclosed
US-4853410-A Hydroxyacetic acid derivatives for the treatment of diabetic complications PFIZER INC. (US) 1989-08-01 US disclosed
WO-1987004344-A1 HYDROXYACETIC ACID DERIVATIVES FOR THE TREATMENT OF DIABETIC COMPLICATIONS PFIZER INC. (US) 1987-07-30 WO disclosed
EP-0230379-A2 Chroman- and thiochroman-4-acetic acids useful in the treatment of diabetic complications PFIZER INC. (US) 1987-07-29 EP disclosed